Cp * Co ( III )‐catalyzed C – H functionalization of bioactive heterocyclic motifs
Bulletin of the Korean Chemical Society · 2025-06 · 46 (6) · 622-635
DOI: 10.1002/bkcs.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of the Korean Chemical Society, online erschienen am 05.06.2025. Verfasst von Yeongmi Park und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cobalt catalysts are emerging as viable alternatives to precious transition metals such as palladium, rhodium, and ruthenium. Compared to rhodium(III) catalysts, cobalt(III) catalysts bearing pentamethylcyclopentadienyl ligands (Cp*) have demonstrated improved reactivity with enhanced chemo‐ or site‐selectivity. Notably, they exhibit robust and sustainable performance in the C–H functionalization of organic substrates, facilitating the synthesis of biologically active molecules. Moreover, this catalytic system is gaining considerable attention for late‐stage modifications owing to its cost‐effectiveness, sustainability, and lower toxicity. This review highlights recent advancements in Cp*Co(III)‐catalyzed C–H functionalization of biologically active scaffolds, including 6‐arylpurines, indoles, quinoline N ‐oxides, and heterocyclic drug molecules.
Zitieren
APA
Park, Y., Park, J., Lee, Y. H., & Son, J. (2025). Cp * Co ( III )‐catalyzed C – H functionalization of bioactive heterocyclic motifs. Bulletin of the Korean Chemical Society, 46(6), 622-635. https://doi.org/10.1002/bkcs.70031
Vancouver
Park Y, Park J, Lee YH, Son J. Cp * Co ( III )‐catalyzed C – H functionalization of bioactive heterocyclic motifs. Bulletin of the Korean Chemical Society. 2025;46(6):622-635. doi:10.1002/bkcs.70031
BibTeX
@article{Park2025,
author = {Park, Yeongmi and Park, Junbeom and Lee, Yong Ho and Son, Jongwoo},
title = {Cp * Co ( III )‐catalyzed C – H functionalization of bioactive heterocyclic motifs},
journal = {Bulletin of the Korean Chemical Society},
year = {2025},
volume = {46},
number = {6},
pages = {622--635},
doi = {10.1002/bkcs.70031}
}
EUVIMED